18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with131I

被引：2
|
作者：
Rosario, Pedro Weslley [1 ]
机构：
[1] Santa Casa Belo Horizonte, Inst Ensino & Pesquisa, Rua Domingos Vieira 590, BR-30150240 Belo Horizonte, MG, Brazil
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / 13期
关键词：
GUIDELINES;
D O I：
10.1007/s00259-020-05039-8
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
8
引用
收藏
页码：2950 / 2951
页数：2
相关论文
共 50 条
  • [1] 18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I
    Pedro Weslley Rosario
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2950 - 2951
  • [2] Response to the letter to the editor "18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I"
    Albano, Domenico
    Tulchinsky, Mark
    Bertagna, Francesco
    Giubbini, Raffaele
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (13) : 2952 - 2953
  • [3] Response to the letter to the editor “18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I”
    Domenico Albano
    Mark Tulchinsky
    Francesco Bertagna
    Raffaele Giubbini
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2952 - 2953
  • [4] Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Bannas, Peter
    Derlin, Thorsten
    Groth, Michael
    Apostolova, Ivayla
    Adam, Gerhard
    Mester, Janos
    Klutmann, Susanne
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (01) : 77 - 85
  • [5] Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Peter Bannas
    Thorsten Derlin
    Michael Groth
    Ivayla Apostolova
    Gerhard Adam
    Janos Mester
    Susanne Klutmann
    Annals of Nuclear Medicine, 2012, 26 : 77 - 85
  • [6] The utility of 18F-FDG-PET/CT in differentiated thyroid cancer patients and elevated thyroglobulin after total thyroidectomy and 131I ablation
    Mladenov, K.
    Spassov, B.
    Vassileva, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S368 - S368
  • [7] Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging 18F-FDG PET/CT
    Okuyucu, Kursat
    Ince, Semra
    Alagoz, Engin
    Emer, Ozdes
    San, Huseyin
    Balkan, Elif
    Ayan, Asli
    Meric, Coskun
    Haymana, Cem
    Acikel, Cengizhan
    Gunalp, Bengul
    Karacalioglu, Alper Ozgur
    Arslan, Nuri
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2016, 19 (03): : 208 - 217
  • [8] Value of 18F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels
    Li, Hongyan
    Chen, Xiaomin
    Zhang, Yajing
    Wang, Kun
    Gao, Zairong
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2869 - 2876
  • [9] Role of PET/CT 18F-FDG in the assessment of differentiated thyroid cancer in patients with negative 131I post-therapy whole body scan and elevated serum thyroglobulin levels
    Vieira, F.
    Azevedo-Silva, F.
    Parracho, M.
    Costa, G.
    Lapa, P.
    Albuquerque, A.
    Pedroso-Lima, J.
    Ferrer-Antunes, A. I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S121 - S121
  • [10] Stratification of recurrent differentiated thyroid cancer with elevated thyroglobulin and negative I-131 whole body scan by restaging 18F FDG PET/CT
    Okuyucu, K.
    Ince, S.
    Alagoz, E.
    Emer, O.
    San, H.
    Balkan, E.
    Ayan, A.
    Gunalp, B.
    Karacalioglu, A. O.
    Arslan, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S649 - S650
12345